Venous Thromboembolism
📧 Sign up to get email alerts when something new happens for Venous Thromboembolism.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2016-01-08Clinical Trial Update: Rivaroxaban in Bariatric Surgery [Phase 1]
Phase 1 trial evaluating rivaroxaban for venous thromboembolism prophylaxis in bariatric surgery patients has completed.
-
CLINICAL_TRIALS trial_result · 2015-12-30Clinical Trial Update: Genetic Epidemiology of Venous Thromboembolism
Mayo Clinic conducted a genetic epidemiology study on venous thromboembolism. The trial status is completed.
-
CLINICAL_TRIALS trial_result · 2015-12-16Clinical Trial Update: Can Thrombin Generation Measurement Predict the Risk of Venous Thromboembolism in Acute Ill Patients
A completed clinical trial evaluated thrombin generation measurement as a predictor of venous thromboembolism risk in acutely ill patients.
-
CLINICAL_TRIALS trial_result · 2015-11-23Clinical Trial Update: Comparing Anti-XA Levels in Post-Cesarean Patients Undergoing Enoxaparin Thromboprophylaxis [Phase 1]
This Phase 1 clinical trial reports results comparing anti-XA levels in women after cesarean delivery who received enoxaparin thromboprophyl…
-
FDA approval · 2015-11-13FDA Approved: HEPARIN SODIUM — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for Heparin Sodium submitted by Fresenius Kabi USA, LLC (NDA 017651). The approval updates labeling …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-10-27Clinical Trial Update: A Study Evaluating Efficacy and Safety of YM150 Compared to Enoxaparin in Subjects Undergoing Hip Replacement Surgery [Phase 2, Phase 3]
A clinical trial comparing YM150 with enoxaparin for prevention of venous thromboembolism in patients undergoing hip replacement, spanning P…
-
FDA approval · 2015-10-26FDA Approved: XARELTO — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental application for XARELTO (rivaroxaban) submitted by Janssen Pharmaceuticals, Inc.
-
CLINICAL_TRIALS withdrawal · 2015-10-26Clinical Trial Update: Pharmacokinetics, Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 2 Years of Age [Phase 2]
A Phase 2 pediatric trial evaluating the pharmacokinetics, safety and tolerability of dabigatran etexilate solution in children aged 1 to le…
-
CLINICAL_TRIALS trial_result · 2015-10-23Clinical Trial Update: Rivaroxaban in Endovenous Laser Ablation With and Without Miniphlebectomy
A completed clinical trial evaluating rivaroxaban in conjunction with endovenous laser ablation, with or without miniphlebectomy, for varico…
-
CLINICAL_TRIALS trial_result · 2015-10-16Clinical Trial Update: Electronic Strategies to Enhance Venous Thromboemboli (VTE) Prophylaxis in Hospitalized Medical Patients [NA]
A completed clinical trial evaluated electronic strategies to enhance venous thromboembolism prophylaxis in hospitalized medical patients.
-
CLINICAL_TRIALS trial_result · 2015-10-14Clinical Trial Update: Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer [Phase 3]
This update notes the termination of a Phase 3 trial evaluating gemcitabine with or without dalteparin in unresectable or metastatic pancrea…
-
CLINICAL_TRIALS trial_result · 2015-10-12Clinical Trial Update: A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients [Phase 3]
A Phase 3 trial evaluating dalteparin prophylaxis in high-risk ambulatory cancer patients was terminated, with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-09-01Clinical Trial Update: Bioequivalence Study of Rivaroxaban [Phase 1]
A Phase 1 bioequivalence study of rivaroxaban conducted by Bayer has completed.
-
CLINICAL_TRIALS trial_result · 2015-09-01Clinical Trial Update: Bioequivalence Study of Rivaroxaban in Japanese Healthy Adult Male Subjects [Phase 1]
Phase 1 bioequivalence study of rivaroxaban in healthy Japanese adult male subjects has completed. Sponsored by Bayer.
-
FDA approval · 2015-08-24FDA Approved: ENOXAPARIN SODIUM — Supplemental Application (Sanofi-Aventis U.S. LLC)
The FDA approved a supplemental application for ENOXAPARIN SODIUM submitted by Sanofi-Aventis U.S. LLC.
-
FDA approval · 2015-08-18FDA Approved: HEPARIN SODIUM IN SODIUM CHLORIDE — Supplemental Application (Baxter Healthcare Corporation)
FDA approved Baxter's Supplemental Application for Heparin Sodium in Sodium Chloride (Heparin Sodium), approving changes to an already-appro…
-
CLINICAL_TRIALS trial_result · 2015-08-14Clinical Trial Update: Angel® Catheter Early Feasibility Clinical Study [NA]
An early feasibility study of BiO2 Medical's Angel Catheter was terminated, with results posted in 2015.
-
CLINICAL_TRIALS withdrawal · 2015-08-10Clinical Trial Update: Predictive Value of Whole Blood Coagulation Parameters for Post-discharge Venous Thromboembolism After Cancer Resection [NA]
This ClinicalTrials.gov update indicates the study evaluating predictive whole-blood coagulation parameters for post-discharge venous thromb…
-
CLINICAL_TRIALS research · 2015-08-07Clinical Trial Update: Epidemiology of Venous Thromboembolism
This document provides an update on the epidemiology of venous thromboembolism from a completed Brigham and Women's Hospital–sponsored trial…
-
CLINICAL_TRIALS trial_result · 2015-08-06Clinical Trial Update: Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects [Phase 1]
A Phase 1 PK/PD study of rivaroxaban in pediatric patients with venous thromboembolism has completed, providing initial pharmacokinetic and …
-
CLINICAL_TRIALS research · 2015-07-21Clinical Trial Update: Tumescent Antibiotic Delivery for Prevention of Surgical Site Infection [Phase 2, Phase 3]
This document provides an update on an ongoing Phase 2/Phase 3 trial evaluating tumescent antibiotic delivery to prevent surgical site infec…
-
CLINICAL_TRIALS research · 2015-07-15Clinical Trial Update: Special Drug Use Investigation (Retrospective) for Arixtra® (Fondaparinux) Venous Thromboembolism Treatment (Over 100kg)
A retrospective Special Drug Use Investigation of fondaparinux (Arixtra) for venous thromboembolism treatment in patients over 100 kg has co…
-
CLINICAL_TRIALS trial_result · 2015-07-07Clinical Trial Update: Screening for Occult Malignancy in Patients With Idiopathic Venous Thromboembolism [NA]
This clinical trial update notes the completion of a study evaluating screening for occult cancer in patients with idiopathic venous thrombo…
-
CLINICAL_TRIALS trial_result · 2015-06-19Clinical Trial Update: Fondaparinux in Critically Ill Patients With Renal Failure [Phase 4]
Phase 4 trial evaluating fondaparinux in critically ill patients with renal failure. The study assessed venous thromboembolism outcomes and …
-
CLINICAL_TRIALS trial_result · 2015-06-18Clinical Trial Update: Adjusted Value of Thromboprophylaxis in Hospitalized Obese Patients: A Comparative Study of Two Regimens of Enoxaparin [Phase 3]
A Phase 3 trial comparing two enoxaparin regimens for thromboprophylaxis in hospitalized obese patients has completed.